MNKD - MannKind Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Westlake Village,
United States
Type: Equity
MNKD price evolution
MNKD
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $97.38 | $193.27 | $238.48 | |
| Short term investments | $151.12 | $107.46 | $56.62 | |
| Net receivables | $18.18 | $23.35 | $19.91 | $14.9 |
| Inventory | $26.66 | $24.75 | $26.44 | $28.55 |
| Total current assets | $327.66 | $325.94 | $383.1 | $373.39 |
| Long term investments | $13.4 | $3.73 | $7.16 | |
| Property, plant & equipment | $98.98 | $85.14 | $83.62 | $84.22 |
| Goodwill & intangible assets | $2.96 | $2.98 | $3 | |
| Total noncurrent assets | $117.9 | $97.78 | $101.81 | |
| Total investments | $164.52 | $111.18 | $63.77 | |
| Total assets | $464.2 | $443.84 | $480.88 | $475.2 |
| Current liabilities | ||||
| Accounts payable | $6.44 | $9.56 | $7.15 | $9.58 |
| Deferred revenue | $73.54 | $75.34 | $78.88 | |
| Short long term debt | $9.94 | $29.87 | $29.81 | |
| Total current liabilities | $72.1 | $80.01 | $99.9 | $104.13 |
| Long term debt | $459.26 | $460.49 | $479.42 | $483 |
| Total noncurrent liabilities | $589.6 | $610.95 | $617.24 | |
| Total debt | $470.43 | $509.29 | $512.81 | |
| Total liabilities | $674.13 | $669.62 | $710.85 | $721.37 |
| Shareholders' equity | ||||
| Retained earnings | -$3209.24 | -$3220.79 | -$3218.78 | -$3229.41 |
| Other shareholder equity | $0.59 | |||
| Total shareholder equity | -$225.78 | -$229.97 | -$246.17 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $238.48 | $69.77 | $124.18 | $67.16 |
| Short term investments | $56.62 | $101.08 | $79.93 | |
| Net receivables | $14.9 | $16.8 | $4.99 | $4.22 |
| Inventory | $28.55 | $21.77 | $7.15 | $4.97 |
| Total current assets | $373.39 | $234.9 | $219.74 | $79.48 |
| Long term investments | $7.16 | $1.96 | $56.62 | |
| Property, plant & equipment | $84.22 | $45.13 | $36.61 | $25.87 |
| Goodwill & intangible assets | $3 | $3.58 | ||
| Total noncurrent assets | $101.81 | $60.39 | $101.42 | $29.13 |
| Total investments | $63.77 | $103.04 | $136.55 | |
| Total assets | $475.2 | $295.28 | $321.16 | $108.61 |
| Current liabilities | ||||
| Accounts payable | $9.58 | $11.05 | $6.96 | $5.58 |
| Deferred revenue | $78.88 | $39.42 | $20.37 | $34.94 |
| Short long term debt | $29.81 | $9.56 | $6.98 | $4.06 |
| Total current liabilities | $104.13 | $67.3 | $48.35 | $73.7 |
| Long term debt | $483 | $368 | $375.77 | $119.38 |
| Total noncurrent liabilities | $617.24 | $478.52 | $482.16 | $215.32 |
| Total debt | $512.81 | $382.91 | $382.74 | $123.44 |
| Total liabilities | $721.37 | $545.82 | $530.51 | $289.03 |
| Shareholders' equity | ||||
| Retained earnings | -$3229.41 | -$3217.47 | -$3130.07 | -$3049.14 |
| Other shareholder equity | ||||
| Total shareholder equity | -$246.17 | -$250.54 | -$209.35 | -$180.42 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $70.08 | $72.39 | $66.26 | $58.47 |
| Cost of revenue | $20.38 | $18.6 | $18.07 | |
| Gross Profit | $52.06 | $52.01 | $47.66 | $40.41 |
| Operating activities | ||||
| Research & development | $11.82 | $10.01 | $9.24 | |
| Selling, general & administrative | $24.11 | $22.33 | $20.54 | |
| Total operating expenses | $36.84 | $35.93 | $32.34 | $29.77 |
| Operating income | $16.08 | $15.32 | $10.63 | |
| Income from continuing operations | ||||
| EBIT | $11.19 | $20.16 | $8.32 | |
| Income tax expense | $1.32 | $0.32 | $0.26 | $1.56 |
| Interest expense | -$7.63 | $12.88 | $9.26 | $5.36 |
| Net income | ||||
| Net income | $11.55 | -$2.01 | $10.63 | $1.4 |
| Income (for common shares) | -$2.01 | $10.63 | $1.4 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $198.96 | $99.77 | $75.44 | $65.14 |
| Cost of revenue | $62.77 | $57.5 | $38.86 | $24.64 |
| Gross Profit | $136.19 | $42.27 | $36.59 | $40.5 |
| Operating activities | ||||
| Research & development | $31.28 | $19.72 | $12.31 | $6.25 |
| Selling, general & administrative | $94.31 | $91.47 | $77.42 | $59.04 |
| Total operating expenses | $125.6 | $111.19 | $90.17 | $80.41 |
| Operating income | $10.59 | -$68.92 | -$53.59 | -$39.91 |
| Income from continuing operations | ||||
| EBIT | $14.78 | -$62.63 | -$64.35 | -$47.99 |
| Income tax expense | $1.56 | -$0.22 | ||
| Interest expense | $25.16 | $24.77 | $16.58 | $9.47 |
| Net income | ||||
| Net income | -$11.94 | -$87.4 | -$80.93 | -$57.24 |
| Income (for common shares) | -$11.94 | -$87.4 | -$80.93 | -$57.24 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$2.01 | $10.63 | $1.4 | |
| Operating activities | ||||
| Depreciation | $2.05 | $1.69 | $1.55 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.43 | $3.88 | $3.81 | |
| Total cash flows from operations | $3.83 | $6.7 | $21.68 | |
| Investing activities | ||||
| Capital expenditures | -$2.97 | -$2.41 | -$5.87 | |
| Investments | -$52.21 | -$46.42 | -$2.02 | |
| Total cash flows from investing | -$144.87 | -$55.18 | -$48.44 | -$7.89 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.96 | $1.36 | $0.74 | |
| Net borrowings | -$40.58 | -$5.1 | $140.9 | |
| Total cash flows from financing | -$50.37 | -$44.55 | -$3.47 | $141.68 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$175.37 | -$95.9 | -$45.21 | $155.46 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$11.94 | -$87.4 | -$80.93 | -$57.24 |
| Operating activities | ||||
| Depreciation | $5.84 | $9.11 | $5.47 | $3.33 |
| Business acquisitions & disposals | -$15.34 | -$3.98 | ||
| Stock-based compensation | $17.65 | $13.45 | $12.2 | $6.51 |
| Total cash flows from operations | $34.09 | -$80.68 | -$61.71 | -$28.13 |
| Investing activities | ||||
| Capital expenditures | -$42.44 | -$7.59 | -$11.47 | -$0.8 |
| Investments | $40.07 | $27.8 | -$140.07 | $20 |
| Total cash flows from investing | -$1.99 | $4.87 | -$151.54 | $15.22 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.6 | $22.49 | $1.95 | $34.75 |
| Net borrowings | $139.09 | -$0.02 | $278.93 | $14.87 |
| Total cash flows from financing | $136.61 | $21.39 | $270.27 | $49.85 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $168.71 | -$54.42 | $57.02 | $36.94 |
News
Fundamentals
| Market cap | $1.49B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 275.78M |
| Revenue | $267.20M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $21.57M |
| Revenue Q/Q | 36.73% |
| Revenue Y/Y | 51.35% |
| P/E ratio | 69.30 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 5.59 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.08 |
|---|---|
| ROA | 4.63% |
| ROE | N/A |
| Debt/Equity | -2.93 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 4.54 |
| Quick ratio | 4.17 |